On December 5, 2024, Melinda Pei, a Director at Rapid Micro Biosystems Inc (RPID, Financial), purchased 20,000 shares of the company. Following this transaction, the insider now owns a total of 54,300 shares. The purchase was documented in a SEC Filing.
Rapid Micro Biosystems Inc is a company that provides innovative products for the detection of microbial contamination in the manufacturing of pharmaceutical, biotechnology, and other products. The company's solutions are designed to improve the quality and safety of products while reducing the time and cost associated with traditional testing methods.
The insider's recent purchase is part of a broader trend within the company. Over the past year, there have been six insider buys and no insider sells at Rapid Micro Biosystems Inc. Melinda Pei alone has purchased a total of 40,000 shares during this period, without selling any.
On the day of the insider's recent acquisition, shares of Rapid Micro Biosystems Inc were trading at $1.02, giving the company a market cap of $44.325 million. The stock's GF Value is estimated at $1.53, resulting in a price-to-GF-Value ratio of 0.67. This suggests that the stock is considered a "Possible Value Trap, Think Twice" based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company's past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
